Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans With Castrate-sensitive Prostate Cancer

The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Veterans with mCRPC. In the real-world that…

Metastatic CancerNeoplasm, Prostate

James J. Peters Veterans Affairs Medical CenterNCT05422911